Literature DB >> 1257296

Calculated beta-ray dose factors for trabecular bone.

J R Whitwell, F W Spiers.   

Abstract

Mean dose factors have been calculated for those tissues in bone that are relevant to the induction of late irradiation effects; namely, red bone marrow and endosteal tissues lining trabecular bone surfaces. The calculations are based on a Monte Carlo computer method for beta-emitting radionuclides which are distributed uniformly throughout the volume of mineralized bone. Results are given for the radionuclides 14C, 45Ca, 22Na, 18F, 32P, 90Y and 90Sr+90Y (all considered for this purpose as volume-seekers) for seven bones from the adult human skeleton and calculations are also presented of average skeletal dose factors. Where possible, results are compared with those derived from other methods based on simple geometrical models.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1257296     DOI: 10.1088/0031-9155/21/1/002

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  7 in total

1.  EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry.

Authors:  Cecilia Hindorf; Gerhard Glatting; Carlo Chiesa; Ola Lindén; Glenn Flux
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-06       Impact factor: 9.236

2.  An image-based skeletal dosimetry model for the ICRP reference adult male--internal electron sources.

Authors:  Matthew Hough; Perry Johnson; Didier Rajon; Derek Jokisch; Choonsik Lee; Wesley Bolch
Journal:  Phys Med Biol       Date:  2011-03-22       Impact factor: 3.609

3.  Depth-dependent concentrations of hematopoietic stem cells in the adult skeleton: Implications for active marrow dosimetry.

Authors:  Amy M Geyer; Bryan C Schwarz; Shannon E O'Reilly; Robert F Hobbs; George Sgouros; Wesley E Bolch
Journal:  Med Phys       Date:  2017-01-30       Impact factor: 4.071

4.  A quantitative study of the structure of trabecular bone in man, rhesus monkey, beagle and miniature pig.

Authors:  A H Beddoe
Journal:  Calcif Tissue Res       Date:  1978-08-18

5.  A bone marrow toxicity model for ²²³Ra alpha-emitter radiopharmaceutical therapy.

Authors:  Robert F Hobbs; Hong Song; Christopher J Watchman; Wesley E Bolch; Anne-Kirsti Aksnes; Thomas Ramdahl; Glenn D Flux; George Sgouros
Journal:  Phys Med Biol       Date:  2012-05-01       Impact factor: 3.609

6.  Radiopharmaceutical therapy of bone metastases with 89SrCl2, 186Re-HEDP and 153Sm-EDTMP: a dosimetric study using Monte Carlo simulation.

Authors:  L Strigari; R Sciuto; M D'Andrea; R Pasqualoni; M Benassi; C L Maini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-01-20       Impact factor: 10.057

7.  Preparation and preclinical evaluation of humanised A33 immunoconjugates for radioimmunotherapy.

Authors:  D J King; P Antoniw; R J Owens; J R Adair; A M Haines; A P Farnsworth; H Finney; A D Lawson; A Lyons; T S Baker
Journal:  Br J Cancer       Date:  1995-12       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.